Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The prospective, randomized, double-blind, placebo-controlled clinical phase II prevention trial NCT05918224 - Streptococcus salivarius K12 & Oral mucositis (Radiotherapy-induced) in patients with Head & Neck squamous cell carcinoma (HNSCC) revealed that Streptococcus salivarius K12 probiotic significantly reduced the incidence, onset, and duration of SOM (severe oral mucositis), while maintaining a good safety profile (1).
(1)
see also:
Oral mucositis (Radiotherapy-induced) & Drugs/Treatments
[Probiotics (living agents) & Oral mucositis (Radiotherap…